As it continues to leverage earnings from its top-selling mRNA-based Covid vaccine to deepen its existing knowhow, Mainz, Germany-based BioNtech has announced plans to...
US specialty chemicals and materials company Chemours will spend $200 million to increase capacity for its Nafion ion exchange membranes at its site in Villers-Saint-Paul...
BASF has broken ground on the third and final phase of its expansion project for polyurethane precursor MDI at its integrated site in Geismar, Louisiana.
Canada’s Fluid Energy Group has sold its global modified and synthetic acid business, including the Triton industrial business, to Dorf Ketal FZE, a wholly owned...
Leading active pharmaceutical ingredients manufacturer EuroAPI plans to invest €40 million at its site in Saint-Aubin-lès-Elbeuf, France, to launch a new production...
Germany‘s Merck has granted an exclusive license for the tumor-targeting IL-12 fusion protein currently known as M9241 to PDS Biotechnology Corporation, a US-based...
US-based multinational contractor KBR and its Japanese acetyls technology partner Showa Denko have been selected by Asian Paints to provide services for a grassroots...
On December 19, 2022, the European Commission proposed a revised regulation on Classification, Labelling and Packaging (CLP) of chemicals and introduced new hazard...
In its first acquisition since forming in 2010, mRNA specialist Moderna is buying Japan’s OriCiro Genomics for $85 million, expanding its therapeutics and vaccines...
